Holen Sie sich die Stockscreener-App
223.19
0.15%
0.1267
Finanzdaten der Axsome Therapeutics Inc-Aktie (AXSM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
14.62%
196.00
|
170.99 | 150.04 | 121.46 | 118.77 |
Operating Expenses
|
2.70%
222.96
|
217.10 | 186.76 | 178.44 | 191.38 |
| Interest Income/Expense |
4.92%
-3.209
|
-3.375 | -4.086 | -5.258 | - |
| Benefits Costs and Expenses |
2.71%
224.13
|
218.22 | 198.97 | 180.88 | 193.59 |
| Costs And Expenses |
2.70%
222.96
|
217.10 | 186.76 | 178.44 | 191.38 |
| Operating Income/Loss |
41.54%
-26.96
|
-46.11 | -36.71 | -56.98 | -72.62 |
| Income/Loss From Continuing Operations Before Tax |
40.44%
-28.13
|
-47.23 | -48.93 | -59.41 | -74.83 |
| Income Tax Expense/Benefit |
0.43
|
- | -0.96 | - | 0.085 |
| Income/Loss From Continuing Operations After Tax |
39.53%
-28.56
|
-47.23 | -47.97 | -59.41 | -74.91 |
|
Net Income/Loss
|
39.53%
-28.56
|
-47.23 | -47.97 | -59.41 | -74.91 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.40%
0.298
|
50.02 | 49.44 | 48.87 | 0.2107 |
| Diluted Average Shares |
99.40%
0.298
|
50.02 | 49.44 | 48.87 | 0.2107 |
| Basic Earnings Per Share |
41.49%
-0.55
|
-0.94 | -0.97 | -1.22 | -1.54 |
| Diluted Earnings Per Share |
41.49%
-0.55
|
-0.94 | -0.97 | -1.22 | -1.54 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.78%
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):